Zonisamide-d4

• CAT Number: R004173
• CAS Number: 1020720-04-0
• Molecular Formula: C8H8N2O3S
• Molecular Weight: 216.25
• Purity: ≥95%
• Synonyms: 1,2-(Benzisoxazole-d4)-3-methanesulfonamide; 3-(Sulfamoylmethyl)-1,2-benzisoxazole-d4; AD 810-d4; Aleviatin-d4; Excegran-d4; PD 110843-d4; Zonegran-d4
• Target: Membrane Transporter/Ion Channel
• Storage: -80°C
• IUPAC Name: (4,5,6,7-tetradeuterio-1,2-benzoxazol-3-yl)methanesulfonamide
• InChI: InChI=1S/C8H8N2O3S/c9-14(11,12)5-7-6-3-1-2-4-8(6)13-10-7/h1-4H,5H2,(H2,9,11,12)/i1D,2D,3D,4D
• InChIKey: UBQNRHZMVUUOMG-RHQRLBAQSA-N
• SMILES: [2H]C1=C(C(=C2C(=C1[2H])C(=NO2)CS(=O)(=O)N)[2H])[2H]

Zonisamide-d4 is a deuterated form of zonisamide, labeled with four deuterium atoms. This compound is vital in the research and development of antiepileptic drugs, specifically in the study of zonisamide’s pharmacokinetics and metabolism. The deuterium labeling allows for precise tracking and quantification in mass spectrometric analyses, providing researchers with accurate data on the drug’s absorption, distribution, metabolism, and excretion. Zonisamide-d4 is a crucial tool for scientists working on optimizing zonisamide therapy, exploring its mechanism of action, and developing improved formulations with enhanced efficacy and reduced side effects.